Insulin and insulin-like growth factor 1 (IGF-1) are closely related hormones involved in the regulation of metabolism and growth. They elicit their functions through activation of tyrosine kinase-type receptors: insulin receptors (IR-A and IR-B) and IGF-1 receptor (IGF-1R). Despite similarity in primary and three-dimensional structures, insulin and IGF-1 bind the noncognate receptor with substantially reduced affinity. We prepared [d-HisB24, GlyB31, TyrB32]-insulin, which binds all three receptors with high affinity (251 or 338% binding affinity to IR-A respectively to IR-B relative to insulin and 12.4% binding affinity to IGF-1R relative to IGF-1). We prepared other modified insulins with the aim of explaining the versatility of [d-HisB24, GlyB31, TyrB32]-insulin. Through structural, activity, and kinetic studies of these insulin analogs, we concluded that the ability of [d-HisB24, GlyB31, TyrB32]-insulin to stimulate all three receptors is provided by structural changes caused by a reversed chirality at the B24 combined with the extension of the C terminus of the B chain by two extra residues. We assume that the structural changes allow the directing of the B chain C terminus to some extra interactions with the receptors. These unusual interactions lead to a decrease of dissociation rate from the IR and conversely enable easier association with IGF-1R. All of the structural changes were made at the hormones' Site 1, which is thought to interact with the Site 1 of the receptors. The results of the study suggest that merely modifications of Site 1 of the hormone are sufficient to change the receptor specificity of insulin.

From the Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Flemingovo n 2 166 10 Prague 6 Czech Republic

Zobrazit více v PubMed

Siddle K. (2012) Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances. Front. Endocrinol. (Lausanne) 3, 34 10.3389/fendo.2012.00034 PubMed DOI PMC

Belfiore A., Frasca F., Pandini G., Sciacca L., and Vigneri R. (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr. Rev. 30, 586–623 10.1210/er.2008-0047 PubMed DOI

Belfiore A., Malaguarnera R., Vella V., Lawrence M. C., Sciacca L., Frasca F., Morrione A., and Vigneri R. (2017) Insulin receptor isoforms in physiology and disease: an updated view. Endocr. Rev. 38, 379–431 10.1210/er.2017-00073 PubMed DOI PMC

De Meyts P., Van Obberghen E., and Roth J. (1978) Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature 273, 504–509 10.1038/273504a0 PubMed DOI

Schäffer L. (1994) A model for insulin binding to the insulin receptor. Eur. J. Biochem. 221, 1127–1132 10.1111/j.1432-1033.1994.tb18833.x PubMed DOI

Xu Y., Kong G. K., Menting J. G., Margetts M. B., Delaine C. A., Jenkin L. M., Kiselyov V. V., De Meyts P., Forbes B. E., and Lawrence M. C. (2018) How ligand binds to the type 1 insulin-like growth factor receptor. Nat. Commun. 9, 821 10.1038/s41467-018-03219-7 PubMed DOI PMC

Kiselyov V. V., Versteyhe S., Gauguin L., and De Meyts P. (2009) Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol. Syst. Biol. 5, 243 PubMed PMC

De Meyts P. (2015) Insulin/receptor binding: the last piece of the puzzle? What recent progress on the structure of the insulin/receptor complex tells us (or not) about negative cooperativity and activation. Bioessays 37, 389–397 10.1002/bies.201400190 PubMed DOI

Kristensen C., Andersen A. S., Hach M., Wiberg F. C., Schäffer L., and Kjeldsen T. (1995) A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor. Biochem. J. 305, 981–986 10.1042/bj3050981 PubMed DOI PMC

Schumacher R., Soos M. A., Schlessinger J., Brandenburg D., Siddle K., and Ullrich A. (1993) Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J. Biol. Chem. 268, 1087–1094 PubMed

Menting J. G., Whittaker J., Margetts M. B., Whittaker L. J., Kong G. K., Smith B. J., Watson C. J., Záková L., Kletvíková E., Jiráček J., Chan S. J., Steiner D. F., Dodson G. G., Brzozowski A. M., Weiss M. A., et al. (2013) How insulin engages its primary binding site on the insulin receptor. Nature 493, 241–245 10.1038/nature11781 PubMed DOI PMC

Ward C. W., Menting J. G., and Lawrence M. C. (2013) The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation. Bioessays 35, 945–954 10.1002/bies.201300065 PubMed DOI

Menting J. G., Lawrence C. F., Kong G. K., Margetts M. B., Ward C. W., and Lawrence M. C. (2015) Structural congruency of ligand binding to the insulin and insulin/type 1 insulin-like growth factor hybrid receptors. Structure 23, 1271–1282 10.1016/j.str.2015.04.016 PubMed DOI

Menting J. G., Yang Y., Chan S. J., Phillips N. B., Smith B. J., Whittaker J., Wickramasinghe N. P., Whittaker L. J., Pandyarajan V., Wan Z. L., Yadav S. P., Carroll J. M., Strokes N., Roberts C. T., Ismail-Beigi F., et al. (2014) Protective hinge in insulin opens to enable its receptor engagement. Proc. Natl. Acad. Sci. U.S.A. 111, E3395–E3404 10.1073/pnas.1412897111 PubMed DOI PMC

Kavran J. M., McCabe J. M., Byrne P. O., Connacher M. K., Wang Z., Ramek A., Sarabipour S., Shan Y., Shaw D. E., Hristova K., Cole P. A., and Leahy D. J. (2014) How IGF-1 activates its receptor. Elife 3, e03772 10.7554/eLife.03772 PubMed DOI PMC

Gutmann T., Kim K. H., Grzybek M., Walz T., and Coskun Ü. (2018) Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor. J. Cell Biol. 217, 1643–1649 10.1083/jcb.201711047 PubMed DOI PMC

Lawrence M. C., McKern N. M., and Ward C. W. (2007) Insulin receptor structure and its implications for the IGF-1 receptor. Curr. Opin. Struct. Biol. 17, 699–705 10.1016/j.sbi.2007.07.007 PubMed DOI

Scapin G., Dandey V. P., Zhang Z., Prosise W., Hruza A., Kelly T., Mayhood T., Strickland C., Potter C. S., and Carragher B. (2018) Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature 556, 122–125 10.1038/nature26153 PubMed DOI PMC

Gauguin L., Delaine C., Alvino C. L., McNeil K. A., Wallace J. C., Forbes B. E., and De Meyts P. (2008) Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J. Biol. Chem. 283, 20821–20829 10.1074/jbc.M802620200 PubMed DOI PMC

Keyhanfar M., Booker G. W., Whittaker J., Wallace J. C., and Forbes B. E. (2007) Precise mapping of an IGF-I-binding site on the IGF-1R. Biochem. J. 401, 269–277 10.1042/BJ20060890 PubMed DOI PMC

Nakagawa S. H., and Tager H. S. (1987) Role of the COOH-terminal B-chain domain in insulin-receptor interactions: identification of perturbations involving the insulin mainchain. J. Biol. Chem. 262, 12054–12058 PubMed

Záková L., Kazdová L., Hanclová I., Protivínská E., Sanda M., Budesínský M., and Jirácek J. (2008) Insulin analogues with modifications at position B26: divergence of binding affinity and biological activity. Biochemistry 47, 5858–5868 10.1021/bi702086w PubMed DOI

Jirácek J., Záková L., Antolíková E., Watson C. J., Turkenburg J. P., Dodson G. G., and Brzozowski A. M. (2010) Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc. Natl. Acad. Sci. U.S.A. 107, 1966–1970 10.1073/pnas.0911785107 PubMed DOI PMC

Antolíková E., Žáková L., Turkenburg J. P., Watson C. J., Hančlová I., Šanda M., Cooper A., Kraus T., Brzozowski A. M., and Jiráček J. (2011) Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface. J. Biol. Chem. 286, 36968–36977 10.1074/jbc.M111.265249 PubMed DOI PMC

Pandyarajan V., Phillips N. B., Rege N., Lawrence M. C., Whittaker J., and Weiss M. A. (2016) Contribution of TyrB26 to the function and stability of insulin: structure-activity relationships at a conserved hormone-receptor interface. J. Biol. Chem. 291, 12978–12990 10.1074/jbc.M115.708347 PubMed DOI PMC

Slieker L. J., Brooke G. S., DiMarchi R. D., Flora D. B., Green L. K., Hoffmann J. A., Long H. B., Fan L., Shields J. E., Sundell K. L., Surface P. L., and Chance R. E. (1997) Modifications in the B10 and B26–B30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia 40, Suppl. 2, S54–S61 10.1007/s001250051402 PubMed DOI

Zhang W., Gustafson T. A., Rutter W. J., and Johnson J. D. (1994) Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity. J. Biol. Chem. 269, 10609–10613 PubMed

Lou M., Garrett T. P., McKern N. M., Hoyne P. A., Epa V. C., Bentley J. D., Lovrecz G. O., Cosgrove L. J., Frenkel M. J., and Ward C. W. (2006) The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Proc. Natl. Acad. Sci. U.S.A. 103, 12429–12434 10.1073/pnas.0605395103 PubMed DOI PMC

Žáková L, Kletvíková E., Veverka V., Lepsík M., Watson C. J., Turkenburg J. P., Jirácek J., and Brzozowski A. M. (2013) Structural integrity of the B24 site in human insulin is important for hormone functionality. J. Biol. Chem. 288, 10230–10240 10.1074/jbc.M112.448050 PubMed DOI PMC

Bayne M. L., Applebaum J., Chicchi G. G., Miller R. E., and Cascieri M. A. (1990) The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J. Biol. Chem. 265, 15648–15652 PubMed

Knudsen L., De Meyts P., and Kiselyov V. V. (2011) Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms. Biochem. J. 440, 397–403 10.1042/BJ20110550 PubMed DOI

Záková L., Kletvíková E., Lepšík M., Collinsová M., Watson C. J., Turkenburg J. P., Jiráček J., and Brzozowski A. M. (2014) Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex. Acta Crystallogr. D Biol. Crystallogr. 70, 2765–2774 10.1107/S1399004714017775 PubMed DOI PMC

Křížková K., Chrudinová M., Povalová A., Selicharová I., Collinsová M., Vaněk V., Brzozowski A. M., Jiráček J., and Žáková L. (2016) Insulin-insulin-like growth factors hybrids as molecular probes of hormone:receptor binding specificity. Biochemistry 55, 2903–2913 10.1021/acs.biochem.6b00140 PubMed DOI

Macháčková K., Collinsová M., Chrudinová M., Selicharová I., Pícha J., Buděšínský M., Vaněk V., Žáková L., Brzozowski A. M., and Jiráček J. (2017) Insulin-like growth factor 1 analogs clicked in the C domain: chemical synthesis and biological activities. J. Med. Chem. 60, 10105–10117 10.1021/acs.jmedchem.7b01331 PubMed DOI

Macháčková K., Chrudinová M., Radosavljević J., Potalitsyn P., Křížková K., Fábry M., Selicharová I., Collinsová M., Brzozowski A. M., Žáková L., and Jiráček J. (2018) Converting insulin-like growth factors 1 and 2 into high-affinity ligands for insulin receptor isoform A by the introduction of an evolutionarily divergent mutation. Biochemistry 57, 2373–2382 10.1021/acs.biochem.7b01260 PubMed DOI

Kurtzhals P., Schäffer L., Sørensen A., Kristensen C., Jonassen I., Schmid C., and Trüb T. (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49, 999–1005 10.2337/diabetes.49.6.999 PubMed DOI

Jørgensen A. M., Olsen H. B., Balschmidt P., and Led J. J. (1996) Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin. J. Mol. Biol. 257, 684–699 10.1006/jmbi.1996.0194 PubMed DOI

Perillo M., and Arnone M. I. (2014) Characterization of insulin-like peptides (ILPs) in the sea urchin Strongylocentrotus purpuratus: insights on the evolution of the insulin family. Gen. Comp. Endocrinol. 205, 68–79 10.1016/j.ygcen.2014.06.014 PubMed DOI

Mizoguchi A., and Okamoto N. (2013) Insulin-like and IGF-like peptides in the silkmoth Bombyx mori: discovery, structure, secretion, and function. Front. Physiol. 4, 217 PubMed PMC

Versteyhe S., Klaproth B., Borup R., Palsgaard J., Jensen M., Gray S. G., and De Meyts P. (2013) IGF-I, IGF-II, and insulin stimulate different gene expression responses through binding to the IGF-I receptor. Front. Endocrinol. (Lausanne) 4, 98 10.3389/fendo.2013.00098 PubMed DOI PMC

Jensen M., Hansen B., De Meyts P., Schäffer L., and Ursø B. (2007) Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. J. Biol. Chem. 282, 35179–35186 10.1074/jbc.M704599200 PubMed DOI

Morcavallo A., Genua M., Palummo A., Kletvikova E., Jiracek J., Brzozowski A. M., Iozzo R. V., Belfiore A., and Morrione A. (2012) Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A. J. Biol. Chem. 287, 11422–11436 10.1074/jbc.M111.252478 PubMed DOI PMC

Záková L., Zyka D., Jezek J., Hanclová I., Sanda M., Brzozowski A. M., and Jirácek J. (2007) The use of Fmoc-Lys(Pac)-OH and penicillin G acylase in the preparation of novel semisynthetic insulin analogs. J. Pept. Sci. 13, 334–341 10.1002/psc.847 PubMed DOI

Sajid W., Holst P. A., Kiselyov V. V., Andersen A. S., Conlon J. M., Kristensen C., Kjeldsen T., Whittaker J., Chan S. J., and De Meyts P. (2009) Structural basis of the aberrant receptor binding properties of hagfish and lamprey insulins. Biochemistry 48, 11283–11295 10.1021/bi901269j PubMed DOI PMC

Late-stage labeling of diverse peptides and proteins with iodine-125

Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation

A radioligand binding assay for the insulin-like growth factor 2 receptor

Zobrazit více v PubMed

PDB
1MSO, 1GZR, 2M2P